Professional Ethics
Professional ethics, perched on the border between science and humanity,
has undergone public scrutiny in modern times. One of the most notable
examinations of professional ethics occurred during the Nuremberg
trial of Nazi medical atrocities in 1946. In recent years, increasing
use of medical technology and the formation of health maintenance
organizations have created a new environment in which medical ethics
are questioned. "Right to Die" debates and health professionals'
sexual misconduct with patients are often in the news.
Administrative bodies struggle with maintaining a balance between protecting
the public and liberty interests.
The Importance of Meaningful Informed Consent for Protecting Patients
and Clinical Research Subjects
Employment & Ethics
In the workplace, the forensic psychiatrist may be asked to consider
whether a claimed disability (e.g., a chronic general illness, such
as Chronic Fatigue Syndrome, a chronic pain syndrome, such as Fibromyalgia,
or a mental disorder, such as Depression or Obsessive-Compulsive
Disorder) is valid and work stress related. Some other frequently
asked employment related examination questions are:
-
"Is a claimed impairment subject to the ADA mandate for accommodation?
-
"What is the appropriate organizational response to a sexual
harassment claim?
-
"What is the validity and extent of sexual harassment-related
damage claims, such as emotional injury or Post-Traumatic Stress
Disorder?
As a nationally recognized forensic neuropsychiatric expert, Dr. Bursztajn
continues to teach via peer review service, publication, and presenting
workshops in recognized professional forums. By way of introduction,
see American
Psychiatric Association workshop abstract on reducing the risk
of dual agency complications by performing objective forensic neuropsychiatric
evaluations of work impairment claims independent of ongoing subjectively
oriented teatment.
Recent Articles in the News
-
Drug
Approved. Is Disease Real? The pharmaceuticalization of medical
diagnosis and disability creation. New York Times, January
14, 2008.
-
Ethics Expert says
Embryo-Implant Docs Negligent. Dr. Bursztajn often consults and
advises clinicians and organizations across the medical and mental
health spectrum as well as state and federal agencies on issues at
the interface of patient care and clinical ethics. This may include
advising the judiciary as an independent or testifying as a plaintiff
or defence retained medical and mental health care and ethics expert. Boston
Herald, January 16, 2004.
-
After
Sanctions, Doctors Get Drug Company Pay. Many doctors who were
sanctioned by a medical board were later paid for research by drug
makers. New York Times, June 3, 2007.
-
Health
Care as Main Engine: Is that so Bad? Whatever the specifics,
executives and economists agree that health care will become a more
important part of the economy. New York Times, November
11, 2001
-
Prozac Maker Reveals
Patient E-Mail Addresses
-
Telemedicine Getting a Test
in Efforts to Cut Costs of Treating Prisoners
-
"Ban Genetic Discrimination" Boston
Globe Op-Ed piece by Dr. Harold J. Bursztajn and Dr. Richard
Sobel, August 7th, 2000.
-
Brave
Good World by Martha Nussbaum, The New Republic,
December 4th, 2000.
-
US Patients Don't Want to Know
How Doctor is Paid by Suzanne Rostler, March 6, 2001.
Conflicts of Interest
-
Drug
Firms accused of biasing doctors' training. Can the pharmaceutical
industry be trusted to fund doctors' compulsory education without
introducing bias? The issue is dividing Congress, academics and drugs
companies. Now, preliminary data have emerged suggesting that industry-sponsored
courses skew training material in favour of commercial interests.
Published in Nature, November 22, 2007.
-
Dr. Bursztajn's recent article with Lisa Cosgrove in the journal
of Organizational
Ethics, Undoing
Undue Industry Influence: Lessons from Psychiatry as Psychopharmacology,
details the need for the uncovering of the hidden ties between
doctors and drug and medical devices companies and the need for
industry critics to be included in the revision and implementation
of conflict-of-interest policies.
Recent Articles in the News
Managed Healthcare
Managed health care organizations are more numerous and pervasive today.
As they have grown in influence, many patients and professionals
have claimed that medical care, while increasing in sophistication,
has declined in quality. At the same time, the large-business and
third-party aspects of managed care organizations can make medical
decision-making an impersonal process, and increase the need for
organizations and clinics to exercise joint responsibility with the
treating physician for informed patient care.
-
Managed-Health-Care
Complications and Clinical Remedies
More and more clinicians practice both primary medical care and
primary psychiatry in the hothouse atmosphere of managed
health care. Dr. Bursztajn has been interested in decision
making under conditions of uncertainty for many years; one
of his earlier books, Medical Choices, Medical Chances, extensively
explores this issue in ways that offer direct assistance
to physicians across the specialty spectrum as to clinical
decisions under conditions of uncertainty. Dr. Bursztajn's
article with Archie Brodsky in Primary Psychiatry examines
the boundaries between medical and psychiatric fundamentals
of clinically-based risk management and provide remedies
for the critical pitfalls facing the practitioner in the
modern era.
-
Responses to a Defective Managed Care Product
Case: Rush
Prudential HMO, Inc. v Moran et al.. In this strong
and very important affirmation of patients' rights, the Court
ruled that ERISA does not override state laws which require HMOs
to provide patients the use of binding independent reviews of
the HMOs' "medical necessity" decisions. It may also
lead the way to considering "product liability" class
action suits viz managed care companies based on a lack of informed
consent. Dr Bursztajn's book chapter previewing this implication
of the decision is a good introduction to this emerging area.
A more complete description of Dr. Bursztajn's recent book chapter
can be Responses to a defective managed care product: medical
negligence, lack of informed consent, and choicelessness. In:
2000 Wiley Expert Witness Update. New York: Aspen
Law Business/Panel Publishers, 2000; 239-264. Bursztajn HJ.
-
"More May Not
Mean Better in Health Care, Studies Find"
Dr. Bursztajn's Letter to the Editor of The New York Times (July
26, 2002) in which he states that "Research like that presented
is all too often misused as a rationalization for policies that
deny access to care and choice of treatments.
-
Protecting
Patient Care and Public Safety in the Managed-Care Era. General
Psychiatric Hospital, Cambridge, MA November 11, 2001 by Harold
J. Bursztajn, M.D.
-
Preserving the Public
Trust. Shaping the Future for Health Participant Programs. The
protection of individuals who volunteer to participate in research
is essential to the ethical conduct or research.
-
Reducing Clinical
Research Risks. Dr. Bursztajn's timely letter to The New
York Times (August, 2001)alerting sponsors of clinical trials
that they are accountable for protecting human subjects from unnecessary
risks due to research.
-
The Ethics of Social Risk Reduction
in the era of the biological Brain
In keeping with our transdisciplinary orientation, in this article
Dr. Bursztajn and co-authors try to do several things at
once. They address research on preventing mental illness
and its relation to existing conceptions of public health,
a topic to which insufficient attention has been paid in
the era of the biological brain, while using this case study
to illustrate the limits of conventional approaches in bioethics.
-
Treatment for Managed Care Pain.
Preventing managed health care malpractice.
-
HMO Reporting in the Crosshairs,
September 25, 2002, JAMA - Poor scoring HMOs more likely
to withhold grades
-
Protecting Subjects, Preserving
Trust, Promoting Progress
Policy and Guidelines for the Oversight of Individual Financial
Interests in Human Subjects Research.
AAMC Task Force on Financial Conflicts of Interest in Clinical
Research, December, 2001.
In October of 2000, in a speech entitled Trust Us to Make A Difference,
Dr. Jordan Cohen, President of the Association of American
Medical Colleges (AAMC), announced the formation of a new
Task Force on Conflicts of Interest in Clinical Research
chaired by Dr. William Danforth, Chancellor Emeritus of Washington
University of St. Louis. Core Principles to Guide Policy
Development. The first product of these efforts is this report.
This document offers guidance to institutions in their efforts
to provide responsible and effective oversight of financial
interests in human subjects research. Academic institutions
share common concerns, yet each retains its own unique culture
and mode of self governance.
-
Program
to Cover Psychiatric Help for 9/11 Families by Erica Goode, The
New York Times, August 21, 2002. The need to provide mental
health care and choices to help 9/11 families given the lack of each
in a managed health care dominated American medical landscape.
-
American Medical News Letter
to the Editor (2.04.02). As managed care pares hospital stays,
more need for physicians to advocate on behalf of patients.
-
Patients' Rights:
What's at Stake? August 16, 2001; The New York Times by
Milt Freudenheim. The new law would mean uniformity for the managed
care companies but we personally will not see much change.
-
Patient Deaths Tied
to Lack of Nurses. Managed health care influences on patient
care; The New York Times, August 8, 2002
-
Kaiser Family Foundation
Releases Study on Currently Enacted Managed Care Liability Provisions
in State Law. Managed care liability: the need for informed consent
as a process.
-
Reducing Violence
in Severe Mental Illness & Community care does not do well.
Why hospitalization is the best hope for reducing mental illness
for those prone to violent behavior.
-
AMA
Principles of Ethics on Managed Health Care
-
RICO Ruling May
13, 2001: U.S. District Judge Federico Moreno today issued a major
ruling in the racketeering lawsuit brought by the country's physicians
against the nation's largest HMOs.
-
Captive Patients, Captive Doctors:
Clinical Dilemmas and Intervention in Caring for Patients in Managed
Health Care by Harold J. Bursztajn, M.D. and Archie Brodsky,
B.A.
-
Medical Negligence and Informed
Consent in the Managed Care Era
-
Substituting Alliance for Alienation:
Supporting the Human Side in Changing Health Care. The changes in
health care, particularly in the doctor-health maintenance organization,
can be better handled using skills already in practice in the patient-doctor
aspect of the health care relationship.
-
Responsibility Without Scapegoating.
The physician, patient, and MCO all have different spheres of authority
and responsibility.
-
A Reflection of My Father's Experiences
with Doctors During the Shoah. A portrait of the traditional
relationship of care between doctor and patient.
-
New Developments in the Role of
Post-Traumatic Stress Disorder in Civil and Criminal Law: A Case
of Medical Malpractice Illustrates the Growing Importance of Informed
Consent.
-
Book Review: Managing
Care, Not Dollars: The Continuum of Mental Health Services
-
Case: Grijalva v. Shalala Federal
court rules that Medicare patients are entitled to immediate hearings,
when denied treatment by HMOs.
-
Case: Failure to Provide Psychiatric Treatment Martino
v. Illionis, Cook County Cir. Ct., No. 97 L 874, July
26, 1999.
-
Dartmouth Research Project findings in Research
Suggests More Health Care May Not Be Better The New York
Times, July 21, 2002.
-
Case: Jamie
Claborn Drewry v. Phillip Harwell, M.D., et al. The uses
of informed consent as a malpractice defense.
-
Case: Shannon
v. HealthAmerica of Pennsylvania. HMO liability.
-
Article: "Report
Says Profit-Making Health Plans Damage Care"
-
Who's Reaping the Benefits. Transcript
of 20/20's program on managed health care.
-
Article: "New
Report on Doctors & Nurses Experience with Managed Care Denials & Patient
Injury"
-
When Health Care Goes Lacking.
Dr. Bursztajn on consequences of managed health care denial in The
New York Times, 8-4-99.
-
Article & Editorial: "Group
Asking U.S. For New Vigilance in Patient Safety"
-
Article: "Medical
Insurers Revise Cost-Control Efforts"
-
Article: "Under
Legal Attack, H.M.O.s Face a Supreme Court Test"
-
Article: "Disabled
Attorney's Novel Strategy Puts A Civil-Rights Spin on HMO Litigation"
-
Excerpt: Hippocrates
or Hypocrisy. Professor Illingworth on HMO ethics conflicts:
Medical vs. Business.
-
Article: "A
Price Too High? A Deal to Save Charter Behavioral May Have Hurt It." Managed
Care Business and Medical Standards & Ethics.
-
Article: "HMO
Accused of Underpaying Doctors"
-
Case: "HMOs
Can Be Vicariously Liable for Their Independent Contractors' Negligence"
-
Article: "National
Class-Action Filed Against Prudential Health Care"
-
Article: "Kaiser
Drug Policy Prompts State Inquiry"
-
Article: "Doctors
Say They Deceive Insurers to Help Patients"
-
Article: "Merrill
Lynch Cuts Health Costs, Creates a Generous Benefit Plan." Minimizing
healthcare costs by maximizing healthcare quality.
-
Article: "Supreme
Court Shields HMOs From Lawsuits"
-
Case: Plocica,
et al. v. NYLCare Health Plans, Inc. The case is expected
to make managed-care insurers more cautious about overruling doctors,
observers say.
-
Article: "Health
and Disability Costs of Depressive Illness in a Major U.S. Corporation." The
cost to employers of failure to treat depression.
-
Article: As
Technology Improves, More People Breathe With Machines. April
24, 2001 Article in the Science Section of The New York Times with
Dr. Bursztajn's response to the editor.
Information on the Commission on Consumer Protection and Quality in the
Health Care Industry can be obtained at The
President's Advisory Commission on Consumer Protection and Quality
Elder Care
Unfortunately, nutrition tends to be neglected for the elderly receiving
home care as well as institutional care. The following provides some
relevant information.
Benefit Denial
Disabilities, including psychiatric disabilities, are controversial reasons
for denial of health benefits or health insurance altogether.
Organizational Responsibility & Ethics
Under some circumstances, managed health care organizations are responsible
for liability. The AMA also considers the plan medical director as
a "physician first."
Organizational Influences
on Clinical Decision Making
ERISA
According to the Pocket Guide to Managed Care,
"The Employee Retirement Income Security Act (ERISA) is a federal
law that governs the rights of employees to employer-sponsored pension
and health benefits. It is supposed to protect patients by preempting
state laws that regulate or tax employee benefits provided by employers.
In theory, ERISA can protect managed care organizations that are sued
for (a) Malpractice, (b) Refusal to pre authorize care, and (c) Denying
payment through their utilization management process. In practice, ERISA's
actual protection of MCOs is variable."
(La Puma, J and D Schiedermayer, McGraw Hill,1996. pp 24-25)
Political activity has also recently increased to address the need for
patient protection.
Biotechnology
-
Genetic Aspects
in Personality Washington Post SCIENCE, July 22,
2002
-
Case: Summary of the case, A.Z.
vs. B.Z. Informed consent and in vitro fertilization.
-
Article: Genes,
Risk, and Managed Care Medicine
-
Article: "Stressful
Life Events, Genetic Liabiltiy, and Onset of an Episode of Major
Depression in Women"
-
Article: "Medicine's
Rude Awakening to the Commercial World" Freedom of Information
vs. Freedom of Innovation
-
Article: "Celera
Says It Is Willing to Share Publication of Gene-Mapping Data" Freedom
of Information vs. Freedom of Innovation
-
Article: "Back
to the Future: Medicine and Our Genes"
Genes & medical choices - on the importance of having the
time to formulate a differential diagnosis, analyze in terms
of probabilities rather than certainties, and to engage in an
informed consent process rather than pro forma pro forma informed
consent.
-
Article: "Even
Techies Are Getting Nervous About Technology" Unintended
but forseeable consequences?
-
Article: "Genes,
Environment, and Mental Health Wellness" Genetics and behavior.
-
Article: "Science,
Medicine, and the Future: Genetic Epidemiology"
-
Article: "Case
at VCU Brings Ethics to Forefront" Genetics researchers
who elicit family medical histories cautioned about informed consent
-
Dr. Bursztajn's letter to
the The New York Times: "Genes, Medicine, & Managed
Care."
-
Article: "Promotion
of the Fittest"
The new science of genetic screening is so precise that it might
just give workplace discrimination a good name.
-
Article: "Massachusetts
Poised to OK Genetic Privacy Bill"
-
Article: "Do
the Dimensions of the Temperament and Character Inventory Map a Simple
Genetic Architecture?" Evidence from Molecular Genetics
and Factor Analysis.
Care for the Dying
Terminally ill patients are often denied certain kinds of medical treatment.
While the process of dying is often depressing, such depression is
rarely treated. Often, this depression leads to giving up on life
rather than the desire to make one's last months feel worthwhile.
There are serious ethical and medical considerations in regard to
best practice treatment for the terminally ill.
Please read Reflections on My Father's
Experiences with Doctors during the Shoah
-
Harvard Medical Alumni Bulletin issue from Autumn 2006 titled "Sparks
of Inspiration" includes the article "Presciptions
for Hope". Lessons from the Holocaust in how doctors can
heal through hope, an adaptation of Dr. Bursztajn's original article
above.
Other articles by Dr. Bursztajn that are of interest in this area are:
-
From PSDA to PTSD: The Patient Self-Determination Act and Post-Traumatic
Stress Disorder, Journal of Clinical Ethics. 1993,
Vol. 4 pp71-74.
-
Authenticity
and Autonomy in the Managed Care Era: Forensic Psychiatric Perspectives, Journal
of Clinical Ethics. 1994, Vol. 5 pp237-242.
-
Clear, Convincing, and Authentic Advance Directives in the Context
of Managed Care? Journal of Clinical Ethics. 1994,
Vol. 5 pp364-366
Privacy & Confidentiality
-
Article: Protecting
Privacy in the Behavioral Genetics Era. In view of the recent
97-0 vote in the Senate to protect genetic privacy and the timeliness
of the issues around genetic privacy, Dr. Bursztajn's article published
by the American Bar Association, Commission on Mental and Physical
Disability Law, 2003 is of great interest and value.
-
Article: "Sacred
Secrets; The Privacy of Medical Records" by Charles A. Welch,
M.D., Massachusetts General Hospital, Boston. Personal Medical Information
is far from private in the United States. Published in New
England Journal of Medicine, August, 2001.
-
Article: "The
Limits of State Laws to Protect Genetic Information" by
George J. Annas, J.D., M.P.H. Protecting Personal DNA Information.
Published in New England Journal of Medicine, August,
2001.
-
Article: "Air
Force Tracks Dumped Records" Dr. Bursztajn quoted in the The
Tampa Tribune, July 16, 1999.
-
Article: The
Logic of Privacy. From The Economist print edition
comes a new way to think about computing and personal information
-
Article: "Long
Reach Into Patients' Privacy"
-
Article: "New
Proposals for Privacy Laws Don't Protect Patients, Groups"
-
Article: "State
to Adopt Privacy Rules on Information From Insurers"
-
The President's Advisory
Commission on Consumer Protection and Quality in the Health Care
Industry
-
Accountability without
Health-Care Data Banks Letter to the Editor of Health Affairs regarding
patient confidentiality and health-care databanks.
-
"Threats
to the Confidentiality of Medical Records: No Place to Hide"
-
Article: "Uses
and Abuses of Prescription Drug Information in Pharmacy Benefits
Management Programs"
-
Notice of
Proposed Rule Making for Standards for Privacy of Individually Identifiable
Health Information
-
Case: Jaffee
v. Redmond (95-266), 518 U.S. 1 (1996).
-
Article: "Kaiser
E-Mail Glitch Highlights Pitfalls of Placing Personal-Health Data
Online"
-
Free
Prozac in the Junk Mail Draws a Lawsuit Ft. Lauderdale, FL, July
3, 2002 The New York Times. How privacy law applies
to medical records used in marketing is an open question.
-
Press Release: Health
and Human Services Proposes Administrative Simplification Standards
for Health Care Transactions
Some questions concerning a national healthcare database:
-
How do we leave control in the hands of patients and allow for informed
consent when data is entered into data bases?
-
How do we prevent Managed Care Organizations (MCOs) from using databases
for enrolling and disenrolling high quality health care providers
[predatory profiling]?
-
How do we protect patient confidentiality from employers, Americans
with Disabilities Act (ADA) aside?
-
Can patients access their own data?
-
Can patients opt out from being included in data bases?
-
How do we inform patients about the experimental nature of health
care data bases in terms of potential negative impacts on patient
health care?
Telemedicine
Interesting articles on Telemedicine:
To obtain Telemedicine: An Overview of Applications and Barriers,
contact: Physician Insurers Association of America, 2275 Research Boulevard,
Suite 250, Rockville, MD 20850. (301) 947-9000.
Dr. Bursztajn has an active patient care practice and consults to physicians,
institutions, judges, and plantiff and defense counsel nationally.